GenMark Diagnostics to Participate in the Canaccord Virtual MedTech & Diagnostics Forum

Rhea-AI Summary

GenMark Diagnostics, Inc. (NASDAQ: GNMK) will participate in the Canaccord Virtual MedTech & Diagnostics Forum on November 19, 2020, at 2:00 p.m. ET. The event will be accessible via live and archived webcasts at ir.genmarkdx.com.

GenMark specializes in automated multiplex molecular diagnostic testing systems, aiming to enhance patient care and reduce costs. Their eSensor XT-8® and ePlex® systems provide efficient solutions for a variety of infectious disease tests. For additional details, visit www.genmarkdx.com.

CARLSBAD, Calif., Nov. 05, 2020 (GLOBE NEWSWIRE) -- GenMark Diagnostics, Inc. (NASDAQ: GNMK) (“GenMark” or the “Company”), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced that the company plans to participate in the upcoming Canaccord Virtual MedTech & Diagnostics Forum.

GenMark’s management team is scheduled to present in a virtual setting on Thursday, November 19^th, 2020 at 2:00 p.m. ET. Interested parties can access the live and archived webcast at ir.genmarkdx.com.

ABOUT GENMARK

GenMark is a leading provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics, and reduce the total cost-of-care. Utilizing GenMark's proprietary eSensor^® detection technology, GenMark's eSensor XT-8^® and ePlex^® systems are designed to support a broad range of molecular diagnostic tests with compact, easy-to-use workstations and self-contained, disposable test cartridges. GenMark’s ePlex: The True Sample-to-Answer Solution™ is designed to optimize laboratory efficiency and address a broad range of infectious disease testing needs, including respiratory, bloodstream, and gastrointestinal infections.  For more information, visit www.genmarkdx.com.

Investor Relations Contact
Leigh Salvo
(415) 937-5404
ir@genmarkdx.com 

FAQ

When is GenMark participating in the Canaccord Virtual MedTech & Diagnostics Forum?

GenMark is scheduled to present on November 19, 2020, at 2:00 p.m. ET.

How can I access the GenMark presentation at the Canaccord Forum?

The presentation will be available through live and archived webcasts at ir.genmarkdx.com.

What does GenMark Diagnostics specialize in?

GenMark specializes in automated multiplex molecular diagnostic testing systems.

What technologies does GenMark use in its diagnostic systems?

GenMark utilizes proprietary eSensor® detection technology in its eSensor XT-8® and ePlex® systems.

What types of infections do GenMark's diagnostic systems test for?

GenMark's systems are designed to address respiratory, bloodstream, and gastrointestinal infections.